First published in International Aquafeed, July-August 2015
Since its inception in 1997, The Global Aquaculture Alliance’s philosophy has been to proactively identify the challenges facing aquaculture and to implement practical solutions that lead to continual improvements over time.
One such challenge is the use of antibiotics in aquaculture. Restrictions on antibiotic use are addressed in great detail in both the Best Aquaculture Practices (BAP) finfish and crustacean farm standards and BAP seafood processing plant standards.
On June 2, GAA further demonstrated its commitment to responsible aquaculture by publishing a survey to gather first-hand information on the use of antibiotics in tilapia farming, the results of which will educate the evolving Best Aquaculture Practices (BAP) program.
An invitation to take the 11-question survey was delivered to about 125 representatives of BAP-certified tilapia farms and processing plants located in China, Columbia, Costa Rica, Ecuador, Guatemala, Honduras, Indonesia, Mexico, Thailand and Vietnam.
This survey primarily concerns the use of antimicrobials listed by the World Health Organisation (WHO) as critical to human health. Some of these substances are permitted for veterinary use. But there are concerns that overuse could potentially, by spreading resistance, reduce the effectiveness of human antimicrobial therapy. Thus, subject to the survey results, GAA will seek by year’s end to modify the tilapia-specific section of the BAP finfish and crustacean farm standards to exclude the use of antimicrobials listed by the WHO as critical to human health.
Some experts feel that antimicrobials listed by the WHO as critical to human health should be excluded from use in tilapia farming. Other experts feel that these antibiotics are critical tools for disease treatment and animal welfare. BAP-certified tilapia farms and processing plants are encouraged to take the survey, which is anonymous.
Read the magazine HERE.
Since its inception in 1997, The Global Aquaculture Alliance’s philosophy has been to proactively identify the challenges facing aquaculture and to implement practical solutions that lead to continual improvements over time.
One such challenge is the use of antibiotics in aquaculture. Restrictions on antibiotic use are addressed in great detail in both the Best Aquaculture Practices (BAP) finfish and crustacean farm standards and BAP seafood processing plant standards.
On June 2, GAA further demonstrated its commitment to responsible aquaculture by publishing a survey to gather first-hand information on the use of antibiotics in tilapia farming, the results of which will educate the evolving Best Aquaculture Practices (BAP) program.
An invitation to take the 11-question survey was delivered to about 125 representatives of BAP-certified tilapia farms and processing plants located in China, Columbia, Costa Rica, Ecuador, Guatemala, Honduras, Indonesia, Mexico, Thailand and Vietnam.
This survey primarily concerns the use of antimicrobials listed by the World Health Organisation (WHO) as critical to human health. Some of these substances are permitted for veterinary use. But there are concerns that overuse could potentially, by spreading resistance, reduce the effectiveness of human antimicrobial therapy. Thus, subject to the survey results, GAA will seek by year’s end to modify the tilapia-specific section of the BAP finfish and crustacean farm standards to exclude the use of antimicrobials listed by the WHO as critical to human health.
 |
| Image: Luna sin estrellas |
Read the magazine HERE.
The Aquaculturists
This blog is maintained by The Aquaculturists staff and is supported by the
magazine International Aquafeed which is published by Perendale Publishers Ltd
For additional daily news from aquaculture around the world: aquaculture-news
No comments:
Post a Comment